Related Experiment Videos
Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells
M R Schneider1, R Zhou, A Hoeflich
1Institute of Molecular Animal Breeding, Gene Center of the Ludwig-Maximilian University, Feodor-Lynen-Strasse 25, D-81377 Munich, Germany. schnder@lmb.uni-muenchen.de
Abstract:
The precise role of insulin-like growth factor-binding protein-5 (IGFBP-5) in regulating the growth of tumor cells, especially of bone-derived malignant cells, is not well understood. We have investigated the biological activity of IGFBP-5 by transfecting OS/50-K8 mouse osteosarcoma cells with an expression vector containing the osteocalcin promoter and the complete mouse IGFBP-5 cDNA (OC-IGFBP-5). Overexpression of IGFBP-5 mRNA and secretion of increased amounts of bioactive protein in conditioned media were demonstrated in different clones. For the analysis of cell proliferation, three clones exhibiting high levels of IGFBP-5 expression were selected and compared to a mock clone and to nontransfected parental cells. IGFBP-5-secreting clones displayed reduced proliferation under both anchorage-dependent and -independent conditions (P < 0.05). The increase in proliferation observed in IGFBP-5-secreting clones after addition of exogenous IGF was significantly lower than that observed in mock-transfected or parental cells. A similar result was obtained with long[R3]IGF-I which has a low affinity for all IGFBPs, suggesting that the inhibitory effect of IGFBP-5 is only partially IGF-dependent. OC-IGFBP-5-transfected clones expressed significantly higher amounts of osteocalcin mRNA (P < 0.05) and secreted more osteocalcin protein than a mock clone or parental OS-50/K8 cells. Thus, part of the growth-inhibiting effect of IGFBP-5 may be due to an induction of differentiation in these cells.
Insights
Insulin-like growth factor-binding protein-5 (IGFBP-5) inhibits osteosarcoma cell growth and promotes differentiation. This finding clarifies IGFBP-5
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The role of insulin-like growth factor-binding protein-5 (IGFBP-5) in bone tumor growth is unclear.
- Understanding IGFBP-5's function is crucial for developing targeted therapies for osteosarcoma.
Purpose of the Study:
- To investigate the biological activity of IGFBP-5 in osteosarcoma cells.
- To determine the effect of IGFBP-5 overexpression on cell proliferation and differentiation.
Main Methods:
- Transfection of OS/50-K8 mouse osteosarcoma cells with an expression vector for IGFBP-5.
- Analysis of IGFBP-5 mRNA and protein expression.
- Assessment of cell proliferation under various conditions and in response to IGF stimulation.
- Measurement of osteocalcin mRNA and protein levels to evaluate differentiation.
Main Results:
- Overexpression of IGFBP-5 led to reduced proliferation in osteosarcoma cells.
- The inhibitory effect of IGFBP-5 on proliferation was partially independent of IGF signaling.
- IGFBP-5 overexpression significantly increased osteocalcin expression, indicating induced differentiation.
Conclusions:
- IGFBP-5 acts as a tumor suppressor in osteosarcoma by inhibiting cell proliferation.
- IGFBP-5 may exert its effects partly through inducing cellular differentiation.
- These findings highlight IGFBP-5 as a potential therapeutic target in bone cancers.